FOR IMMEDIATE RELEASE November 19, 2020- After hiking the Continental Divide for the past five months, Jonathan Maidment completes his third hiking journey and achieves the Triple Crown! Maidment adds this last hike of the Continental Divide Trail to complete this...
“Joe Zuraw has been a friend to the Alpha-1 Community for more than 20 years, he has worked tirelessly on behalf of patients his entire career. This honor could not be a better tribute to both Joe and also towards the John W. Walsh Translational Research Award....
Miami, October 30, 2020 – Each year, the Alpha-1 Foundation recognizes November as Alpha-1 Awareness Month in order to raise awareness for Alpha-1 Antitrypsin Deficiency (Alpha-1) around the United States. This special month is commemorated by the wide variety of...
“We are grateful for Vertex’s expedited and direct communication with the Alpha-1 Community in releasing the attached statement about discontinuing their clinical trial of VX-814 targeting the small molecule correction of alpha-1 antitrypsin deficiency (AATD). Vertex...
“The announcement today of the collaboration between Takeda and Arrowhead for a licensure deal for ARO-AAT, a phase 2 investigational RNA interference (RNAi) therapy for Alpha-1 liver disease is met with great excitement. Both companies are long standing partners...
